Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction

Using papaverine, papaverine/phentolamine, or prostaglandin E1 (PGE1), intracavernosal pharmacotherapy has been successful in treating erectile dysfunction. The limiting factor of using these medicines is intracorporeal fibrosis with the first two and a high cost with PGE1. Our experience with intra...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of physical medicine and rehabilitation 1994-03, Vol.75 (3), p.276-278
Hauptverfasser:	CHAO, R, CLOWERS, D. E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Alprostadil - economics Alprostadil - pharmacology Alprostadil - therapeutic use Biological and medical sciences Cost-Benefit Analysis Drug Combinations Drug Costs Drug Monitoring Drug Synergism Erectile Dysfunction - drug therapy Erectile Dysfunction - etiology Erectile Dysfunction - physiopathology Fibrosis Follow-Up Studies Genital system. Reproduction Humans Injections Male Medical sciences Middle Aged Multiple Sclerosis - complications Papaverine - economics Papaverine - pharmacology Papaverine - therapeutic use Patient Satisfaction Penile Diseases - chemically induced Penile Diseases - pathology Penile Erection - drug effects Pharmacology. Drug treatments Phentolamine - economics Phentolamine - pharmacology Phentolamine - therapeutic use Priapism - chemically induced Prostatectomy - adverse effects Spinal Cord Injuries - complications
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!